Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Bone Marrow Mesenchymal Stem Cells
Authors:
- Livia RosetiLivia Roseti
- Marta SerraMSMarta Serra
- Alessandra BassiABAlessandra Bassi
- 5 August 2014
- book chapter
- Published by Springer Nature
- Vol. 1283, 171-186
Abstract
According to the European Regulation (EC 1394/2007), Mesenchymal Stem Cells expanded in culture for clinical use are considered as Advanced Therapy Medicinal Products. As a consequence, they must be produced in compliance with Good Manufacturing Practice in order to ensure safety, reproducibility, and efficacy. Here, we report a Standard Operating Procedure describing the Good Manufacturing Practice-compliant production of Bone Marrow-derived Mesenchymal Stem Cells suitable for autologous implantation in humans. This procedure can be considered as a template for the development of investigational medicinal Mesenchymal Stem Cells-based product protocols to be enclosed in the dossier required for a clinical trial approval. Possible clinical applications concern local uses in the regeneration of bone tissue in nonunion fractures or in orthopedic and maxillofacial diseases characterized by a bone loss.Keywords
This publication has 11 references indexed in Scilit:
- Cellular therapies for the treatment of non-union: The past, present and futureInjury, 2013
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical TrialsPLOS ONE, 2012
- Clinical applications of mesenchymal stem cellsJournal of Hematology & Oncology, 2012
- Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical UseStem Cells International, 2011
- Good Manufacturing Practices Production of Mesenchymal Stem/Stromal CellsHuman Gene Therapy, 2010
- High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrowCytotherapy, 2010
- Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformationBlood, 2010
- Sinus augmentation using human mesenchymal stem cells loaded into a β-tricalcium phosphate/hydroxyapatite scaffoldOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Roadmap to approval: use of an automated sterility test method as a lot release test for Carticel®, autologous cultured chondrocytesCytotherapy, 2005